Hong Leong Bank Berhad (KLSE:HLBANK)

Market Cap	39.56B
Revenue (ttm)	6.67B
Net Income (ttm)	4.22B
Shares Out	2.05B
EPS (ttm)	2.05
PE Ratio	9.42
Forward PE	9.32
Dividend	0.71 (3.72%)
Ex-Dividend Date	Mar 12, 2025

Volume	874,400
Average Volume	628,315
Open	19.02
Previous Close	19.10
Day's Range	19.02 - 19.30
52-Week Range	18.42 - 21.88
Beta	0.15
RSI	50.61
Earnings Date	Aug 29, 2025

About CTI BioPharma

Hong Leong Bank Berhad operates as a financial services company in Malaysia, Singapore, Hong Kong, China, Vietnam, and Cambodia. The company operates through Commercial Banking, Investment Banking and Asset Management, Insurance, and Other Operations segments. Its deposit products include current, savings, salary, SME current, foreign currency, and business flexi fixed and fixed deposit accounts, as well as fixed and premium deposits, and safe deposit boxes. The company also offers personal, property, auto, business cash, business auto, busines...

• Industry: Commercial Banks
• Founded: 1905
• Employees: 7,987
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: HLBANK

Financial Performance

In 2024, Hong Leong Bank Berhad's revenue was 5.88 billion, an increase of 5.63% compared to the previous year's 5.57 billion. Earnings were 4.20 billion, an increase of 9.90%.